Daflon (Micronized Purified Flavonoid Fraction) for Hemorrhoids
Recommended Dosage and Duration
For acute hemorrhoidal crisis, administer Daflon 500 mg as 3 tablets twice daily (total 3000 mg/day) for 4 days, then reduce to 2 tablets twice daily (total 2000 mg/day) for 3 additional days. 1, 2 This 7-day intensive regimen targets the acute inflammatory phase when symptoms are most severe.
For chronic or recurrent hemorrhoids, prescribe 2 tablets of Daflon 500 mg daily (total 1000 mg/day) for 60–83 days to reduce frequency, duration, and severity of symptoms. 2, 3, 4 Studies demonstrate statistically significant improvement in bleeding, pain, heaviness, pruritus, and anal discharge with this maintenance dosing. 3, 4
Critical Dosing Context
- Daflon must always be combined with dietary fiber (25–30 g/day, achievable with 5–6 teaspoons psyllium husk mixed with 600 mL water) and adequate hydration—flavonoid monotherapy is ineffective for sustained symptom control. 1
- The World Society of Emergency Surgery recommends flavonoids to relieve symptoms in complicated hemorrhoids (weak recommendation, Grade 2B based on moderate-quality evidence). 5, 1
- A Cochrane meta-analysis of 24 randomized controlled trials (2,334 participants) demonstrated statistically significant benefits for pruritus, bleeding, post-hemorrhoidectomy bleeding, discharge, leakage, and overall symptom scores. 1, 6
Common Side Effects
Gastrointestinal and autonomic symptoms are the most frequently reported adverse events, but Daflon's tolerability profile is similar to placebo. 2 In a prospective study of 105 patients, only 5 (4.8%) experienced gastrointestinal side effects, and none required medication discontinuation. 4
- Mild nausea, dyspepsia, or diarrhea may occur but rarely necessitate treatment cessation. 2, 4
- No systemic cardiovascular or metabolic side effects have been documented in clinical trials. 2
Contraindications
The only absolute contraindication is documented hypersensitivity to diosmin, hesperidin, or other flavonoid compounds. 1 No other specific contraindications appear in the guideline literature or drug formulation studies. 2, 7
Special Populations
- Pregnancy: Daflon is not explicitly contraindicated during pregnancy, though bulk-forming agents (psyllium), osmotic laxatives (polyethylene glycol, lactulose), and hydrocortisone foam are the preferred first-line agents in the third trimester. 8
- Lactation: No data exist regarding excretion in breast milk; clinical judgment is required.
Criteria for Referral to Procedural or Surgical Therapy
Refer for procedural intervention when conservative management (fiber, hydration, Daflon) fails after 8–12 weeks, or immediately if any red-flag features are present. 1, 8
Immediate Referral Indications (Red Flags)
- Anemia (hemoglobin drop or symptomatic fatigue, pallor, dyspnea): Never attribute anemia to hemorrhoids without colonoscopy to exclude proximal colonic pathology—hemorrhoids alone cause anemia in only 0.5 per 100,000 population. 1, 8
- Positive fecal occult blood test: Hemorrhoids do not cause positive guaiac; full colonoscopy is mandatory to rule out inflammatory bowel disease, colorectal cancer, or diverticular disease. 1, 8
- Atypical bleeding pattern: Maroon or dark blood, blood mixed with stool, or bleeding without defecation warrants colonoscopy. 5, 8
- Severe pain: Uncomplicated internal hemorrhoids are painless; severe pain suggests thrombosed external hemorrhoid, anal fissure, abscess, or strangulated prolapsed hemorrhoid. 5, 8
Elective Referral Indications (After Failed Conservative Therapy)
- Grade I–II internal hemorrhoids with persistent bleeding or prolapse after 8–12 weeks of Daflon plus fiber: Rubber band ligation is first-line procedural therapy, with 70.5–89% success rates. 8, 9
- Grade III hemorrhoids (prolapse requiring manual reduction): Rubber band ligation or surgical hemorrhoidectomy, depending on symptom severity and patient preference. 8
- Grade IV hemorrhoids (irreducible prolapse): Surgical hemorrhoidectomy is indicated, with 90–98% success and 2–10% recurrence. 8
- Thrombosed external hemorrhoid presenting >72 hours after onset: If conservative management (topical 0.3% nifedipine with 1.5% lidocaine every 12 hours for 2 weeks) fails, consider delayed excision. 1, 8
- Thrombosed external hemorrhoid presenting ≤72 hours after onset: Complete surgical excision under local anesthesia provides faster pain relief and lower recurrence than conservative therapy. 1, 8
Important Caveats and Common Pitfalls
Symptom Recurrence
Symptom recurrence reaches 80% within 3–6 months after cessation of Daflon therapy, indicating the need for ongoing dietary measures or definitive procedural treatment. 1, 8 Patients must understand that flavonoids provide symptomatic relief but do not cure the underlying vascular pathology.
Pain Relief Limitations
Pain relief with Daflon may not reach statistical significance, though benefits for bleeding, pruritus, and overall symptoms are well-established. 1, 6 For acute pain in thrombosed external hemorrhoids, topical 0.3% nifedipine with 1.5% lidocaine (92% resolution rate) is superior to flavonoids alone. 1, 8
Topical Corticosteroid Misuse
Limit topical corticosteroids to ≤7 days to prevent perianal tissue thinning and increased injury risk—this applies to all formulations regardless of potency. 5, 1, 9 Corticosteroids are adjuncts for local inflammation, not substitutes for Daflon or fiber.
Misattribution of Symptoms
Never assume all anorectal symptoms are hemorrhoids. Anal fissure coexists in up to 20% of hemorrhoid patients and causes severe pain during defecation. 8 Abscess, fistula, condyloma, polyp, prolapse, or anorectal cancer can mimic hemorrhoidal symptoms. 5
Surgical Pitfalls
Never perform simple incision and drainage of thrombosed external hemorrhoids—this leads to persistent bleeding and higher recurrence; complete excision is required if surgical intervention is chosen. 5, 1, 8
Mechanism of Action and Pharmacokinetics
Daflon (90% micronized diosmin, 10% hesperidin) improves venous tone, enhances lymphatic drainage, and reduces capillary hyperpermeability by protecting the microcirculation from inflammatory processes. 2 Micronization to particles <2 μm increases diosmin absorption by 77% compared to non-micronized formulations (57.9% vs. 32.7% urinary excretion). 7